title: Renoprotective therapy: is it blood pressure or albuminuria that matters?
authors.affiliation: Division of Nephrology, Department of Medicine, University Medical Center Groningen, 9713 GZ Groningen, Netherlands. p.e.de.jong@int.umcg.nl
authors.forename: Paul E
authors.initials: PE
authors.lastname: De Jong
authors.forename: Dick
authors.initials: D
authors.lastname: de Zeeuw
mesh_terms: D000419:Albuminuria; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage; D000959:Antihypertensive Agents / Q000008:administration & dosage*; D001794:Blood Pressure; D018450:Disease Progression; D004359:Drug Therapy, Combination; D015736:Felodipine / Q000008:administration & dosage; D006801:Humans; D007674:Kidney Diseases / Q000150:complications / Q000503:physiopathology* / Q000652:urine; D007676:Kidney Failure, Chronic / Q000517:prevention & control; D017257:Ramipril / Q000008:administration & dosage
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D017257:Ramipril; D015736:Felodipine